Basit öğe kaydını göster

dc.contributor.authorSÖZER TOKDEMİR, Selçuk
dc.contributor.authorWANG, X
dc.contributor.authorZHANG, W
dc.contributor.authorISHII, T
dc.contributor.authorWANG, J
dc.contributor.authorXU, M
dc.contributor.authorHOFFMAN, R
dc.date.accessioned2021-03-04T10:43:10Z
dc.date.available2021-03-04T10:43:10Z
dc.date.issued2009
dc.identifier.citationWANG X., ZHANG W., ISHII T., SÖZER TOKDEMİR S., WANG J., XU M., HOFFMAN R., ""Correction of the abnormal trafficking of primary myelofibrosis CD34+ cells by treatment with chromatin-modifying agents."Correction of the abnormal trafficking of primary myelofibrosis CD34+ cells by treatment with chromatin-modifying agents.""Correction of the abnormal trafficking of primary myelofibrosis CD34+ cells by treatment with chromatin-modifying agents."", CANCER RESEARCH, cilt.vol.69, sa.19, ss.7612-7618, 2009
dc.identifier.issn0008-5472
dc.identifier.otherav_6ea20038-d634-459c-bd2d-9ba4e5efd5f4
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/76381
dc.language.isoeng
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectKlinik Tıp (MED)
dc.title"Correction of the abnormal trafficking of primary myelofibrosis CD34+ cells by treatment with chromatin-modifying agents."Correction of the abnormal trafficking of primary myelofibrosis CD34+ cells by treatment with chromatin-modifying agents.""Correction of the abnormal trafficking of primary myelofibrosis CD34+ cells by treatment with chromatin-modifying agents."
dc.typeMakale
dc.relation.journalCANCER RESEARCH
dc.contributor.departmentAbd , ,
dc.identifier.volumevol.69
dc.identifier.issue19
dc.identifier.startpage7612
dc.identifier.endpage7618
dc.contributor.firstauthorID696972


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster